[ad_1]
Synopsis
PharmEasy seems to have cemented its position as India’s largest online pharmacy firm with the addition of Thyrocare. It now has a diversified portfolio of offerings and a strong back-end support. With this added muscle, the more than six-year-old startup is now ready to compete with the likes of Tata-backed 1mg, Reliance-Netmeds, and Apollo Hospitals’ 24×7.
It is hard to miss the youthful exuberance of Siddharth Shah, CEO and co-founder of India’s leading online pharmacy PharmEasy. Last week, API Holdings, its parent company, bagged a 66% stake in publicly listed diagnostic chain Thyrocare Technologies in a deal valued at over INR4,546 crore. A mandatory open offer for another 26% shares takes the payout for the business closer to the billion-dollar mark and sets precedence where an unlisted
- FONT SIZE
AbcSmall
AbcMedium
AbcLarge
Sign in to read the full article
You’ve got this Prime Story as a Free Gift
₹399/month
Monthly
PLAN
Billed Amount ₹399
₹208/month
(Save 49%)
Yearly
PLAN
Billed Amount ₹2,499
15
Days Trial
+Includes DocuBay and TimesPrime Membership.
₹150/month
(Save 63%)
2-Year
PLAN
Billed Amount ₹3,599
15
Days Trial
+Includes DocuBay and TimesPrime Membership.
Already a Member? Sign In now
Why ?
Exclusive Economic Times Stories, Editorials & Expert opinion across 20+ sectors
-
Stock analysis. Market Research. Industry Trends on 4000+ Stocks
-
Clean experience with
Minimal Ads -
Comment & Engage with ET Prime community -
Exclusive invites to Virtual Events with Industry Leaders -
A trusted team of Journalists & Analysts who can best filter signal from noise
[ad_2]
Source link
